DFK-62306-84619
3 vaccinations
8 coded responses
37 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 984 / WA
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
GKM-23642-16555
Child or adolescent in my care · Male · 2022-06-27
Timeline
-
2021-03-27
Registered in v-safe
-
2021-03-27
Dose 1 — Pfizer-BioNTech
- 2021-03-27
- 2021-03-28
-
2021-03-29
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: FairFree text: Sore throat. Nasal CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: FairFree text: Sore throat, Nasal CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion, Oropharyngeal pain, Paranasal sinus discomfort — Feeling: FairFree text: Nasal Congestion, Sinus Pressure, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion, Oropharyngeal pain, Paranasal sinus discomfort — Feeling: FairFree text: Nasal Congestion, Sore Throat, Sinus PressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion, Oropharyngeal pain, Paranasal sinus discomfort — Feeling: GoodFree text: Sore Throat, Nasal Congestion, Sinus PressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Survey response — day 7, dose 1MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: GoodFree text: Nasal Congestion, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-10
-
2021-04-17
Dose 2 — Pfizer-BioNTech
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-07-17
- 2021-10-16
-
2021-12-22
Dose 3 — Pfizer-BioNTech
-
2021-12-24
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-26
- 2021-12-27
- 2021-12-28
- 2021-12-29
- 2022-01-05
- 2022-01-12
- 2022-01-19
- 2022-01-26
-
2022-02-02
Survey response — day 42, dose 3MedDRA: Oropharyngeal pain, Rhinorrhoea, Upper-airway cough syndrome — Feeling: GoodFree text: Slightly runny nose. Slightly sore throat from post nasal drip.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-23
Survey response — 3 months, dose 3MedDRA: Exposure to SARS-CoV-2, Malaise — Feeling: Good · Be unable to work or attend schoolFree text: Had exposure to covid-19 positive and experienced covid symptoms thereafter.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-22
- 2022-12-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Pfizer-BioNTech | |
| 2 | 2021-04-17 | Pfizer-BioNTech | |
| 3 | 2021-12-22 | Pfizer-BioNTech | No |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat. Nasal Congestion
Systemic reaction (other): Sore throat, Nasal Congestion
Systemic reaction (other): Nasal Congestion, Sinus Pressure, sore throat
Systemic reaction (other): Nasal Congestion, Sore Throat, Sinus Pressure
Systemic reaction (other): Sore Throat, Nasal Congestion, Sinus Pressure
Release 6 — day 7, dose 1
Systemic reaction (other): Nasal Congestion, sore throat
Release 11 — day 42, dose 3
Symptoms: Slightly runny nose. Slightly sore throat from post nasal drip.
Release 11 — 3 months, dose 3
Symptoms: Had exposure to covid-19 positive and experienced covid symptoms thereafter.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release